Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States
The purpose of this study is to assess early treatment failure within 100 days and to assess the effect of this regimen on engraftment, GVHD, immune recovery, relapse of malignancy and survival.
Leukemia|Non Hodgkin's Lymphoma|Aplastic Anemia
PROCEDURE: Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation
The purpose of this study is to assess early treatment failure within 100 days and to assess the effect of this regimen on engraftment, GVHD, immune recovery, relapse of malignancy and survival.